<?xml version="1.0" encoding="UTF-8"?>
<p>The clinical isolates of yeast (
 <italic>Candida glabrata</italic> 1402m, 
 <italic>C. krusei</italic> 1447m, 
 <italic>Cryptococcus laurentii</italic> 801m, 
 <italic>S. cerevisiae</italic> 77 S) and 
 <italic>Aspergillus</italic> spp. (
 <italic>A. tereus</italic> 1133 m, 
 <italic>A. flavus</italic> 905 m, 
 <italic>A. fumigatus</italic> 163) from immunocompromised patients with invasive pulmonary aspergillosis and acute invasive candidiasis were taken from the Collection of Mycological Laboratory of the Moscow Municipal Scientific Practical Center of Tuberculosis Control (Russia). All clinical isolates demonstrated azole resistance in vitro to commercial fluconazole and itraconazole.
</p>
